Physician profile
Eric J Boyd
NPI 1255355285
$7,258.56
in general payments reported to CMS, 2019-2025
30 companies · $671 in 2025
The $671 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,965 · 2020: $490 · 2021: $2,063 · 2022: $292 · 2023: $502 · 2024: $276 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,448.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $1,767.90 | 2021-2022 | |
| Vertiflex, INC. | $1,516.19 | 2019 | |
| Medtronic, INC. | $518.15 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Nevro Corp. | $484.30 | 2019-2023 | Senza |
| Amgen INC. | $440.69 | 2019-2024 | Evenity, Prolia |
| Abbott Laboratories | $360.40 | 2019-2025 | Proclaim |
| Spr Therapeutics, INC | $289.09 | 2019-2023 | Sprint Pns System |
| Boston Scientific Corporation | $275.20 | 2019-2025 | Wavewriter Alpha Prime 16, Ams 700 |
| Nalu Medical, INC. | $269.35 | 2023-2025 | Nalu Neurostimulation System |
| Bioventus LLC | $209.71 | 2019-2025 | |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Scilex Pharmaceuticals INC. | $177.20 | 2019-2020 | |
| Stryker Corporation | $166.69 | 2025 | Salvation |
| Radius Health, INC. | $112.71 | 2019-2021 | |
| Tersera Therapeutics LLC | $92.23 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $63.94 | 2019-2022 | |
| Medtronic USA, INC. | $56.60 | 2019-2020 | |
| Pacira Therapeutics, INC. | $56.21 | 2019 | |
| Biotronik Nro, INC. | $28.40 | 2025 | Prospera |
| Relievant Medsystems, INC. | $25.35 | 2020 | |
| Ferring Pharmaceuticals INC. | $23.97 | 2023 | Euflexxa |
| Tactile Systems Technology INC | $23.37 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.01 | 2019 | |
| Daiichi Sankyo INC. | $17.96 | 2019 | |
| Molnlycke Health Care US, LLC | $17.93 | 2024 | Mepilex Border Post-Op Ag, Avance |
| Kowa Pharmaceuticals America, INC. | $16.17 | 2023 | Seglentis |
| Orthofix Medical, INC. | $15.02 | 2024 | Physio-Stim |
| Collegium Pharmaceutical, INC. | $14.76 | 2019 | |
| Lilly USA, LLC | $11.92 | 2020 | |
| Dynasplint Systems INC. | $5.71 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,300.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.